Following a 2002 study which found that taking daily aspirin was likely a good way to prevent a heart attack or stroke, aspirin was widely marketed to mostly healthy people. Early in 2009, the same group of scientists published an updated analysis, concluding that any benefits of aspirin in preventing heart attack or stroke are likely counterbalanced (and possibly outweighed) by an increased risk of bleeding. Some experts now believe that physicians just are not hearing the "new" news about aspirin and that potentially millions of Americans may be at risk.
Read "Mounting debate over aspirin use in primary prevention should prompt new talks with patients"
See the contest questionnaire in which the reporter writes about how this story was written.